Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation ...
Pulse Biosciences (Nasdaq:PLSE) announced today that it enrolled the first patients in its NANOPULSE-AF study.
CorTec GmbH, a pioneer in fully implantable brain-computer interfaces (BCI), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the ...
Pulse Biosciences (PLSE) highlights promising AFib catheter data and IDE-cleared pivotal trial progress—plus thyroid ...
U.S. IDE Enrollment follows groundbreaking 96% procedural success at 12 months in European feasibility study Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary ...
ASI Alliance and Matterhorn introduce safe blockchain coding with vibecoding, simplifying dApp creation on ASI:Chain for developers.
CorTec today announced that it received FDA breakthrough device designation for its Brain Interchange brain-computer ...
SUNNYVALE, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- eGain (NASDAQ: EGAN) today announced new enterprise AI platform ...
Miro's AI Workflows turn visual brainstorms into finished deliverables. Sidekicks and Flows cut innovation cycles from weeks ...
Cryptopolitan on MSN
Matterhorn, ASI Alliance target bug-free smart contract future in Web3 vibecoding launch
Matterhorn and ASI Alliance will launch a new environment for vibecoding Web3 apps, with higher audit and security standards.
Matterhorn, creator of the AI-native vibecoding IDE for blockchain development, today announced a strategic partnership with ASI Alliance (SingularityNET, Fetch.ai and CUDOS) to bring accessible, ...
Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced a $50 million growth financing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results